Skip to content
BidBenchmark

Contract award

VENATORX PHARMACEUTICALS INC

IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
PIID
HHSN272201600029C
Award key
CONT_AWD_HHSN272201600029C_7529_-NONE-_-NONE-
Recipient UEI
MBBKNBU5DCC6
Source as of
Current award value
$48,517,0793
Obligated to date
$48,517,0792
Potential with options
$48,517,0793
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Malvern, Pennsylvania
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition13 offers received
Period of performance
Sep 19, 2016Mar 31, 2026Through Mar 31, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 19, 2016Initial award$7,098,583.00$48,517,078.64
1Feb 3, 2017M$0.00$48,517,078.64
2Sep 12, 2017C$9,174,369.00$48,517,078.64
3Feb 26, 2018G$3,974,779.00$48,517,078.64
4Sep 19, 2018C$2,828,870.00$48,517,078.64
P00005Dec 12, 2018G$1,169,969.00$48,517,078.64
P00006Jan 24, 2019B$0.00$48,517,078.64
P00007Mar 27, 2019G$2,522,045.00$48,517,078.64
P00008May 29, 2019G$7,234,848.00$48,517,078.64
P00009Aug 28, 2019B$1,369,025.00$48,517,078.64
P00010Sep 11, 2019M$0.00$48,517,078.64
P00011Nov 20, 2019B$0.00$48,517,078.64
P00012Mar 3, 2020B$0.00$48,517,078.64
P00013Apr 22, 2020B$1,155,623.00$48,517,078.64
P00014Sep 3, 2020B$1,926,565.00$48,517,078.64
P00015Sep 28, 2020B$0.00$48,517,078.64
P00016Dec 30, 2020B$0.00$48,517,078.64
P00017Mar 9, 2021B$439,651.00$48,517,078.64
P00018Jun 14, 2021B$0.00$48,517,078.64
P00019Sep 16, 2021G$3,975,473.27$48,517,078.64
P00020Sep 28, 2021C-$0.71$48,517,078.64
P00021Mar 4, 2022B$2,284,288.00$48,517,078.64
P00022Aug 3, 2022B$0.00$48,517,078.64
P00023Jan 6, 2023B$0.00$48,517,078.64
P00024Jun 7, 2023B$3,344,053.19$48,517,078.64
P00025Jun 28, 2024B$0.00$48,517,078.64
P00026Aug 20, 2024B$370,320.96$48,517,078.64
P00027Sep 10, 2024C-$94,722.95$48,517,078.64
P00028May 22, 2025B$0.00$48,517,078.64
P00029Sep 23, 2025C-$195,932.03$48,517,078.64
P00030Jul 31, 2026C-$60,728.09$48,517,078.64

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.27b84aced6443

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 31 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSN272201600029C — VENATORX PHARMACEUTICALS INC · BidBenchmark